Research

IncobotulinumtoxinA efficacy/safety in upper-limb spasticity in pediatric cerebral palsy

22 Apr 2026
10 minute read
Pediatric Neurology
Like
Copy link
Save

This resource published in the Frontiers in Neurology journal, evaluates the safety and efficacy of incobotulinumtoxinA for paediatric upper-limb spasticity across GMFCS I–V, including combined limb treatment.

Spastic cerebral palsy (CP), affecting ~80% of cases, presents with heterogeneous upper and/or lower limb involvement. Botulinum toxin type A (BoNT-A) is widely used for focal spasticity. 

Journal: Pediatric Neurology [International]

*CP specific information

External Content

What does this mean?

We've sourced this content from a third party. At the time we published this, we decided it was useful and valuable information.

Because we aren't in control of the original file, we aren't able to guarantee the quality of the content will always be up to our standards.